NEKTAR THERAPEUTICS
For the period ended Jun 4, 2026. Filed Apr 24, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 4, 2026 · Filed Apr 24, 2026
Contents
PAY VERSUS PERFORMANCE
In accordance with rules adopted by the Securities and Exchange Commission pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we provide the following disclosure regarding executive compensation for our principal executive officer (“PEO”) and Non-PEO NEOs and Company performance for the fiscal years listed below. The Compensation Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown.
| Year · Summary Compensation Table Total for PEO(1)($) · Compensation Actually Paid to PEO(1),(2),(3)($) · Average Summary Compensation Table Total for Non-PEO NEOs(1) ($) · Average Compensation Actually Paid to Non-PEO NEOs(1),(2),(3) ($) · Value of Initial Fixed $100 Investment based on:(4) · Net Income($ Millions) | |||||||
|---|---|---|---|---|---|---|---|
| TSR ($) · Peer Group TSR ($) | |||||||
| 2025 | 6,256,954 | 14,140,399 | 1,224,886 | 1,923,109 | 16.58 | 124.75 | (164) |
| 2024 | 3,762,693 | 5,354,245 | 1,123,266 | 1,427,279 | 5.47 | 93.49 | (119) |
| 2023 | 3,135,576 | (773,200) | 1,122,330 | (2,644) | 3.32 | 94.03 | (276) |
| 2022 | 11,275,830 | (8,738,814) | 3,091,330 | (3,426,582) | 13.29 | 89.90 | (368) |
| 2021 | 11,153,616 | 8,032,023 | 4,377,734 | 3,290,039 | 79.47 | 100.02 | (524) |
| (1) | Howard W. Robin was our PEO for each year presented. The individuals comprising the Non-PEO NEOs for each year presented are listed below. |
| 2021 | 2022 | 2023 | 2024-2025 |
| Gil M. Labrucherie | Gil M. Labrucherie | Jillian B. Thomsen | Sandra Gardiner |
| Mark A. Wilson | Jillian B. Thomsen | Sandra Gardiner | Mark A. Wilson |
| Jonathon Zalevsky | Mark A. Wilson | Mark A. Wilson | Jonathan Zalevsky |
| John Northcott | Jonathon Zalevsky | Jonathon Zalevsky | |
| John Northcott | |||
|---|---|---|---|
| (2) | The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below. |
| (3) | Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the Exclusion of Stock Awards and Option Awards column are the totals from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table. |
| Year | Summary Compensation Table Total for PEO ($) | Exclusion of Stock Awards and Option Awards for PEO ($) | Inclusion of Equity Values for PEO ($) | Compensation Actually Paid to PEO ($) |
|---|---|---|---|---|
| 2025 | 6,256,954 | (3,928,616) | 11,812,061 | 14,140,399 |
| Year | Average Summary Compensation Table Total for Non-PEO NEOs ($) | Average Exclusion of Stock Awards and Option Awards for Non-PEO NEOs ($) | Average Inclusion of Equity Values for Non-PEO NEOs ($) | Average Compensation Actually Paid to Non-PEO NEOs ($) |
|---|---|---|---|---|
| 2025 | 1,224,886 | (377,749) | 1,075,972 | 1,923,109 |
The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:
| Year | Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for PEO ($) | Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for PEO ($) | Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for PEO ($) | Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for PEO ($) | Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for PEO ($) | Total - Inclusion ofEquity Values for PEO ($) |
|---|---|---|---|---|---|---|
| 2025 | 4,719,276 | 4,839,837 | — | 2,252,948 | — | 11,812,061 |
| Year | Average Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Non-PEO NEOs ($) | Average Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Non-PEO NEOs ($) | Average Vesting-Date Fair Value of Equity Awards Granted During Year that Vested During Year for Non-PEO NEOs ($) | Average Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Non-PEO NEOs ($) | Average Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year for Non-PEO NEOs ($) | Total - Average Inclusion ofEquity Values for Non-PEO NEOs ($) |
|---|---|---|---|---|---|---|
| 2025 | 453,773 | 415,572 | — | 366,491 | (159,864) | 1,075,972 |
| 4. | The Peer Group TSR set forth in this table utilizes the NASDAQ Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Form 10-K for the year ended December 31, 2025. The comparison assumes $100 was invested for the period starting December 31, 2020, through the end of the listed year in the Company and in the NASDAQ Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. |
Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Total Shareholder Return (“TSR”)
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and the cumulative TSR over the five most recently completed fiscal years for the Company.
Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Net Income
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and our net income during the five most recently completed fiscal years.
We believe that our compensation structure supports our business strategy while successfully aligning executive focus and interests with those of the Company and our stockholders. We seek to incentivize long-term performance and achievement of milestones that are important to building sustained success for the Company.
Our compensation structure includes several elements that collectively provide an effective compensation strategy that supports our philosophy of pay for performance. As discussed in the Compensation Discussion and Analysis section, the performance-based component of our NEOs’ compensation is tied to the achievement of critical objective, performance milestones and annual corporate goals, which we believe provides strong performance incentives to our executives.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.